Updates on the Current Treatments for Diabetic Retinopathy and Possibility of Future Oral Therapy

Retinal Diseases

Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging With Ultrawide-Field Imaging for Determining Severity of Diabetic Retinopathy

JAMA Ophthalmol.

Aiello LP, Odia I, Glassman AR, Melia M, Jampol LM, Bressler NM, Kiss S, Silva PS, Wykoff CC, Sun JK, Diabetic Retinopathy Clinical Research Network

doi: 10.1001/jamaophthalmol.

Retinal Diseases

Anti-VEGF Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions

Am J Ophthalmol.

Wubben TJ, Johnson MW, Anti-VEGF Treatment Interruption Study Group

doi: 10.1016/j.ajo.2019.03.005.

COMMENTED

Retinal Diseases

Association of Statin Therapy With Prevention of Vision-Threatening Diabetic Retinopathy

JAMA Ophthalmol.

Kang EY, Chen TH, Garg SJ, Sun CC, Kang JH, Wu WC, Hung MJ, Lai CC, Cherng WJ, Hwang YS

doi: 10.1001/

Retinal Diseases

Observational outcomes in proliferative diabetic retinopathy patients following treatment with ranibizumab, panretinal laser photocoagulation or combination therapy - The non-interventional second year follow-up to the PRIDE study

Acta Ophthalmol

Lang GE, Stahl A, Voegeler J, Quiering C, Zaremba L, Lorenz K, Spital G, Liakopoulos S

doi: 10.1111/aos.14907

COMMENTED

Retinal Diseases

PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Should Baseline Characteristics Affect Choice of Treatment?

Retina.

Bressler SB, Beaulieu WT, Glassman AR, Gross JG, Melia M, Chen E, Pavlica MR, Jampol LM; Diabetic Retinopathy Clinical Research Network.

doi: 10.1097/

COMMENTED

Retinal Diseases

Retinal Nonperfusion Characteristics on Ultra-Widefield Angiography in Eyes With Severe Nonproliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy

JAMA Ophthalmol.

Nicholson L, Ramu J, Chan EW, Bainbridge JW, Hykin PG, Talks SJ, Sivaprasad S

doi: 10.1001/jamaophthalmol.

Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology

Ophthalmology.

VanderVeen DK, Melia M, Yang MB, Hutchinson AK, Wilson LB, Lambert SR

doi: 10.1016/

RECOMMENDED

Retinal DiseasesSurgery and Intervention

Durability of Diabetic Retinopathy Improvement with As-Needed Ranibizumab: Open-label Extension of RIDE and RISE Studies

Ophthalmology.

Sun JK, Wang PW, Taylor S, Haskova Z

doi: 10.1016/j.ophtha.2018.10.041.

COMMENTED

Retinal DiseasesDry Eye Disease

Topical Treatment With Brimonidine and Somatostatin Causes Retinal Vascular Dilation in Patients With Early Diabetic Retinopathy From the EUROCONDOR

Invest Ophthalmol Vis Sci.

Grauslund J, Frydkjaer-Olsen U, Peto T, Fernández-Carneado J, Ponsati B, Hernández C, Cunha-Vaz J, Simó R, EUROCONDOR.

doi: 10.1167/iovs.18-26487.

Related content

Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging With Ultrawide-Field Imaging for Determining Severity of Diabetic Retinopathy

Anti-VEGF Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions

Association of Statin Therapy With Prevention of Vision-Threatening Diabetic Retinopathy

Observational outcomes in proliferative diabetic retinopathy patients following treatment with ranibizumab, panretinal laser photocoagulation or combination therapy - The non-interventional second year follow-up to the PRIDE study

PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Should Baseline Characteristics Affect Choice of Treatment?

Retinal Nonperfusion Characteristics on Ultra-Widefield Angiography in Eyes With Severe Nonproliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy

Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology

Durability of Diabetic Retinopathy Improvement with As-Needed Ranibizumab: Open-label Extension of RIDE and RISE Studies

Topical Treatment With Brimonidine and Somatostatin Causes Retinal Vascular Dilation in Patients With Early Diabetic Retinopathy From the EUROCONDOR